Sarcopenia and cognitive ageing: investigating their interrelationship, biological correlates and the role of glucocorticoids
View/ Open
Kilgour2015.docx (3.539Mb)
Date
29/06/2015Author
Kilgour, Alexandra Helen Middleton
Metadata
Abstract
Background
Sarcopenia and age-related cognitive decline (ARCD) are important age-related conditions
which significantly impact upon the quality of life of older adults. ARCD is a well-established
research area, whereas sarcopenia is a relatively new field. Research into the
inter-relationships between them and possible common underlying mechanistic processes is
lacking.
Methods
Several research techniques were used: a large systematic review; the development of an
image analysis technique to measure neck muscle size on volumetric MR brain scans; the
subsequent use of the technique in elderly cohort studies; statistical modelling to investigate
the role of glucocorticoids in sarcopenia; and an invasive clinical study to develop a novel
technique to measure the activity of 11beta-hydroxysteroid dehydrogenase (11βHSD1) in the
human brain in vivo.
Results
I consistently found a relationship between: some measures of brain structure and muscle
size; markers of brain structure and muscle function, mostly grip strength and gait speed; and
cognition and muscle function. However, I found no relationship between current cognition
and muscle size in any of the above studies. Cortisol was identified as a possible explanatory
factor in the relationship between both cognition and brain volume with gait speed. I found an
association between markers of immunosenescence and sarcopenia (neck muscle CSA and
grip strength) and an association between expression of the cortisol amplifying enzyme
11βHSD1 and quadriceps strength.
I developed a technique to measure 11βHSD1 activity across the human brain, which found
that the amount of cortisol produced within the brain was not detectable and highlighted the
asymmetries within the cerebrovascular venous system.
Conclusions
Further longitudinal studies looking at the association between sarcopenia and ARCD are
now required to investigate these important relationships further and hopefully this will lead
to improved therapeutic options.